mesalamine has been researched along with Granuloma, Plasma Cell in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Granuloma, Plasma Cell: A slow-growing benign pseudotumor in which plasma cells greatly outnumber the inflammatory cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amankonah, TD | 1 |
| Strom, CB | 1 |
| Vierling, JM | 1 |
| Petrovic, LM | 1 |
1 other study available for mesalamine and Granuloma, Plasma Cell
| Article | Year |
|---|---|
Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Diagnosis, Differential; Granuloma, P | 2001 |